NCT02893917 2026-03-18Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting90 enrolled 19 charts